tSCS in Children With Spina Bifida
Recruiting
N/A
Interventional Study
Spina Bifida
Myelomeningocele
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 4 – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 20 (estimated)
- Sponsor
- Bailey Petersen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
* Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
* Between the ages of 4 and 17 years of age.
* Documented neurogenic bladder dysfuncti…
Contacts